Should we centralise care for the patient suspected of having ovarian malignancy?

dc.contributor.authorGeomini, P.
dc.contributor.authorKruitwagen, R.
dc.contributor.authorBremer, G.
dc.contributor.authorMassuger, L.
dc.contributor.authorMol, B.
dc.date.issued2011
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityPeggy M.A.J. Geomini, Roy F.P.M. Kruitwagen, Gérard L. Bremer, Leon Massuger, Ben Willem J. Mol
dc.identifier.citationGynecologic Oncology, 2011; 122(1):95-99
dc.identifier.doi10.1016/j.ygyno.2011.03.005
dc.identifier.issn0090-8258
dc.identifier.issn1095-6859
dc.identifier.orcidMol, B. [0000-0001-6887-0262] [0000-0001-8337-550X]
dc.identifier.urihttp://hdl.handle.net/2440/86215
dc.language.isoen
dc.publisherElsevier
dc.rights© 2009 Elsevier Inc. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.ygyno.2011.03.005
dc.subjectOvarian cancer; Centralised care; Cost effective analysis; Gynecologic oncologist; Risk of malignancy index
dc.titleShould we centralise care for the patient suspected of having ovarian malignancy?
dc.typeJournal article
pubs.publication-statusPublished

Files